Giant axonal neuropathy

Jump to navigation Jump to search

WikiDoc Resources for Giant axonal neuropathy

Articles

Most recent articles on Giant axonal neuropathy

Most cited articles on Giant axonal neuropathy

Review articles on Giant axonal neuropathy

Articles on Giant axonal neuropathy in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Giant axonal neuropathy

Images of Giant axonal neuropathy

Photos of Giant axonal neuropathy

Podcasts & MP3s on Giant axonal neuropathy

Videos on Giant axonal neuropathy

Evidence Based Medicine

Cochrane Collaboration on Giant axonal neuropathy

Bandolier on Giant axonal neuropathy

TRIP on Giant axonal neuropathy

Clinical Trials

Ongoing Trials on Giant axonal neuropathy at Clinical Trials.gov

Trial results on Giant axonal neuropathy

Clinical Trials on Giant axonal neuropathy at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Giant axonal neuropathy

NICE Guidance on Giant axonal neuropathy

NHS PRODIGY Guidance

FDA on Giant axonal neuropathy

CDC on Giant axonal neuropathy

Books

Books on Giant axonal neuropathy

News

Giant axonal neuropathy in the news

Be alerted to news on Giant axonal neuropathy

News trends on Giant axonal neuropathy

Commentary

Blogs on Giant axonal neuropathy

Definitions

Definitions of Giant axonal neuropathy

Patient Resources / Community

Patient resources on Giant axonal neuropathy

Discussion groups on Giant axonal neuropathy

Patient Handouts on Giant axonal neuropathy

Directions to Hospitals Treating Giant axonal neuropathy

Risk calculators and risk factors for Giant axonal neuropathy

Healthcare Provider Resources

Symptoms of Giant axonal neuropathy

Causes & Risk Factors for Giant axonal neuropathy

Diagnostic studies for Giant axonal neuropathy

Treatment of Giant axonal neuropathy

Continuing Medical Education (CME)

CME Programs on Giant axonal neuropathy

International

Giant axonal neuropathy en Espanol

Giant axonal neuropathy en Francais

Business

Giant axonal neuropathy in the Marketplace

Patents on Giant axonal neuropathy

Experimental / Informatics

List of terms related to Giant axonal neuropathy


Giant axonal neuropathy is a rare inherited condition that causes disorganization of neurofilaments. Neurofilaments form a structural framework that helps to define the shape and size of neurons and are essential for normal nerve function.

Giant axonal neuropathy generally appears in infancy or early childhood, and slowly progresses as more cells become involved. Signs of giant axonal neuropathy usually begin in the peripheral nervous system, which controls the arms, legs and many other areas of the body. Most individuals with this disorder first have problems with walking. Later they may lose sensation, coordination, strength, and reflexes in their limbs. Hearing or vision problems may also occur. Extremely kinky hair is characteristic of giant axonal neuropathy, appearing in almost all affected people. As the disorder progresses, central nervous system becomes involved. This may cause a gradual decline in mental function, loss of control of body movement, and seizures.

Giant axonal neuropathy is caused by mutations in the GAN gene, which provides instructions for making a protein called gigaxonin. Some GAN mutations affect the shape of the protein, changing how it binds to others in organizing the structure of the neuron. Other mutations result in the absence of any functional gigaxonin protein.

Neurons affected by a mutated GAN gene accumulate excess neurofilaments in the axon, the long extension from the nerve cell that transmits its signal to other nerve cells and to muscles. These distended or giant axons do not transmit signals properly and eventually deteriorate, resulting in problems with movement and other nervous system functions. The disease is inherited in an autosomal recessive pattern which means both parents must have mutated GAN genes.

This article incorporates public domain text from The U.S. National Library of Medicine


Template:WikiDoc Sources